310.ai
Generative AI + Designer Biology
San Francisco, United States · Founded 2022 · $4.0M raised
- Headquarters
- San Francisco
- Employees
- 11–50
- Founded
- 2022
- Business Model
- B2B
- Website
- 310.ai
- Total Funding
- $4.0M
- Last Round
- $4.0M SeedDec 2022
- Rounds
- 1
About
310.ai is a team of scientists and technologists building an AI operating system for life sciences, applying generative AI to design novel proteins and enable programmable biology. Founded in 2022 by CEO Koosh Azimian, a former Facebook AI tech lead, and Stanford-trained computational protein designer Kathy Wei, the San Francisco company left top research institutions and biotech firms to pursue the convergence of AI and biology.
Summary
310.ai is an Artificial Intelligence company based in San Francisco, United States, founded in 2022. It has raised $4.0M in total across 1 round, most recently a $4.0M Seed round in Dec 2022. Investors include Cota Capital, Ascend Vietnam Ventures and E14 Fund.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Dec 2022
Investors
Similar Companies
AI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...
OpenAI is an AI research and deployment company dedicated to ensuring that general-purpose artifi...
Anthropic is an AI research company that builds reliable, interpretable, and steerable AI systems.
xAI is an AI platform for accelerating human scientific discovery.
Waymo is an autonomous driving technology company with a mission to make it safe and easy for peo...
Databricks is the pioneer of the data lakehouse, a unified platform for data science, machine lea...